PUBLIC CONTRACT · 2025
Aquisição de MIRVETUXIMAB SORAVTANSINA IV 5 MG/ML 20M, AUE no 202504044, ao Lab. Abbvie, para a ULSASI para o ano de 2025
- Contract value
- €47,331.36
- Signed on
- 30 October 2025
- Procedure
- Contratação excluída II
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 15461699PUBLISHED SUBJECT
Aquisição de MIRVETUXIMAB SORAVTANSINA IV 5 MG/ML 20M, AUE no 202504044, ao Lab. Abbvie, para a ULSASI para o ano de 2025
Parties involved
- Place of performance
- Portugal, Lisboa, Amadora
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- ABBVIE,LDA · Tax ID 510229050
Values and timeline
- Contract price
- €47,331.36
- Procedure base price
- €47,331.36
- Total effective price
- Not reported on Portal BASE
- Publication date
- 6 August 2026
- Award date
- 30 October 2025
- Signing date
- 30 October 2025
- Performance period
- 62 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Contratação excluída II
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- artigo 5.º n.º 1 do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 11411463
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.